Aclaris Therapeutics Correlations

Stocks . USA . 
Stock . Aclaris Therapeutics
ACRS Stock  USD 3.99  0.19  5.00%   
The current 90-days correlation between Aclaris Therapeutics and Genetron Holdings is -0.05 (i.e., Good diversification). The correlation of Aclaris Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.

Aclaris Therapeutics Correlation With Market

Good diversification

The correlation between Aclaris Therapeutics and DJI is -0.04 (i.e., Good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Aclaris Therapeutics and DJI in the same portfolio, assuming nothing else is changed.
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Aclaris Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
For more information on how to buy Aclaris Stock please use our How to Invest in Aclaris Therapeutics guide.

Moving together with Aclaris Stock

  0.76BMY Bristol Myers Squibb Sell-off TrendPairCorr
  0.79MDGL Madrigal PharmaceuticalsPairCorr
  0.73MNPR Monopar TherapeuticsPairCorr
  0.63RNXT RenovoRxPairCorr

Moving against Aclaris Stock

  0.91INZY Inozyme PharmaPairCorr
  0.88LLY Eli Lilly Sell-off TrendPairCorr
  0.88PFE Pfizer Inc Aggressive PushPairCorr
  0.79ME 23Andme HoldingPairCorr
  0.79JNJ Johnson Johnson Fiscal Year End 28th of January 2025 PairCorr
  0.78MRK Merck Company Fiscal Year End 6th of February 2025 PairCorr
  0.67VALN Valneva SE ADRPairCorr
  0.66LEGN Legend Biotech CorpPairCorr
  0.65GMAB Genmab ASPairCorr
  0.65IPSC Century TherapeuticsPairCorr
  0.62A Agilent TechnologiesPairCorr
  0.58CINGW Cingulate WarrantsPairCorr
  0.44EQ EquilliumPairCorr
  0.77AMGN Amgen Inc Sell-off TrendPairCorr
  0.72NKTX Nkarta IncPairCorr
  0.69PHAT Phathom PharmaceuticalsPairCorr
  0.67MTEM Molecular TemplatesPairCorr
  0.62ABBV AbbVie IncPairCorr
  0.51LYRA Lyra TherapeuticsPairCorr
  0.47SNDX Syndax PharmaceuticalsPairCorr
  0.45PCVX VaxcytePairCorr
  0.42ALEC AlectorPairCorr
  0.38BGNE BeiGenePairCorr
  0.35ASND Ascendis Pharma ASPairCorr
  0.34APLS Apellis PharmaceuticalsPairCorr
  0.33MDWD MediwoundPairCorr

Related Correlations Analysis

Click cells to compare fundamentals   Check Volatility   Backtest Portfolio

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.
High positive correlations   
BDSX
+ 0.95
MYGN
QGEN
+ 0.74
NEOG
MYGN
+ 0.74
QGEN
SYNH
+ 0.73
OLK
RDNT
+ 0.72
OLK
BDSX
+ 0.66
QGEN
  
High negative correlations   
MYGN
- 0.92
OLK
BDSX
- 0.91
OLK
BDSX
- 0.77
RDNT
OLK
- 0.76
QGEN
MYGN
- 0.75
RDNT
BDSX
- 0.69
SYNH

Risk-Adjusted Indicators

There is a big difference between Aclaris Stock performing well and Aclaris Therapeutics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Aclaris Therapeutics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
NEOG  2.11 (0.30) 0.00 (0.04) 0.00 
 0.00 
 4.11 
(6.46)
 11.75 
QGEN  1.02 (0.22) 0.00 (0.20) 0.00 
 0.00 
 2.06 
(2.05)
 5.80 
OLK  0.63  0.15  0.06  1.30  0.48 
(0.76)
 1.58 
(1.37)
 4.37 
SYNH  0.67  0.12 (0.02)(0.57) 0.85 
(0.76)
 2.13 
(1.42)
 9.20 
SHC  1.71 (0.40) 0.00 (0.17) 0.00 
 0.00 
 3.45 
(3.99)
 13.40 
RDNT  2.00  0.24  0.13  0.28  1.84 
(2.16)
 3.77 
(2.61)
 22.33 
MYGN  2.19 (0.90) 0.00 (1.32) 0.00 
 0.00 
 4.24 
(6.12)
 27.15 
GTH  1.87  0.05 (0.03)(0.10) 2.49 
(2.24)
 3.45 
(4.08)
 14.43 
BDSX  2.58 (0.38) 0.00  3.60  0.00 
 0.00 
 5.66 
(5.61)
 29.48 
CSTL  2.49  0.00  0.02  0.12  2.81 
(2.91)
 5.90 
(4.38)
 19.49 

Aclaris Therapeutics Corporate Executives

Elected by the shareholders, the Aclaris Therapeutics' board of directors comprises two types of representatives: Aclaris Therapeutics inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Aclaris. The board's role is to monitor Aclaris Therapeutics' management team and ensure that shareholders' interests are well served. Aclaris Therapeutics' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Aclaris Therapeutics' outside directors are responsible for providing unbiased perspectives on the board's policies.
Frank RuffoCFO CoFounderProfile
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY